Form 8-K - Current report:
SEC Accession No. 0001326732-25-000057
Filing Date
2025-06-13
Accepted
2025-06-13 16:01:14
Documents
12
Period of Report
2025-06-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K xncr-20250612.htm   iXBRL 8-K 46880
  Complete submission text file 0001326732-25-000057.txt   162277

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xncr-20250612.xsd EX-101.SCH 1779
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xncr-20250612_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xncr-20250612_pre.xml EX-101.PRE 12506
14 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20250612_htm.xml XML 2728
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36182 | Film No.: 251046311
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)